← SynDRA
ORMETOPRIM
SynDRA canonical compound SYN0014368 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | P2RX3 |
|---|
| Mechanism of action | Bacterial antifolate |
|---|
| Indication | coccidiosis |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- Bacterial antifolate
- folic acid antagonist
Cross-references
Synonyms
- ormetroptim
- RO-59754
- NSC-95072
- Ormetoprime
- Ormetoprima
- Ormetroprim
- RO-5-9754
- 2,4-Diamino-5-(6-methylveratryl)pyrimidine
- Ormetoprimum
- NSC 95072
- M3EFS94984
- NSC95072
- Ro-59754
- DTXCID9026689
- RefChem:58581
- Ormethoprim
- Ormetorprim
- component of Rofenaid
- 5-(4,5-diMethoxy-2-Methylbenzyl)-2,4-diaminopyrimidine
- 5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine
- MFCD00057747
- NCGC00167523-01
- SMR000466374
- CAS-6981-18-6
- Ormetoprim [USAN:INN]
- Ormetoprime [INN-French]
- Ormetoprimum [INN-Latin]
- Ormetoprima [INN-Spanish]
- UNII-M3EFS94984
- EINECS 230-246-6
- Diamino-5-(6-methylveratryl)pyrimidine
- ORMETOPRIM [INN]
- ORMETOPRIM [JAN]
- Ormetoprim (USAN/INN)
- ORMETOPRIM [USAN]
- ORMETOPRIM [MART.]
- Pyrimidine, 2,4-diamino-5-(6-methylveratryl)-
- NCIOpen2_006334
Look up ORMETOPRIM in the interactive SynDRA portal →